Michelle Ann Ting, MD

Michelle Ann Ting, MD

Cancer and Blood Disorders Center, Neuroblastoma Program, Bone Tumors and Soft Tissue Tumors, I-131-MIBG Therapy, Solid Tumors Oncology, Cancer Predisposition Clinic Team

On staff since August 2019

Children's Title: Attending Physician, Cancer and Blood Disorders Center

Academic Title: Clinical Assistant Professor, Pediatrics

Research Center: Ben Towne Center for Childhood Cancer Research

"It is my privilege to be a part of my patients’ lives in their fight against pediatric cancer. I strive to deliver the level of compassion and medical expertise that I would insist upon for my own loved ones to ensure that patients are supported and well cared for throughout every step of the journey. I am also motivated to move the needle in pediatric cancer outcomes by caring for and implementing cancer screening regimens for children with an increased risk of developing cancer. "

  • Michelle Ting, MD, is an attending physician at Seattle Children’s Hospital and Clinical Assistant Professor of pediatrics at the University of Washington School of Medicine. She holds board certifications in Pediatrics and Pediatric Hematology/Oncology. She completed her Pediatrics Residency at UT Southwestern Medical School and Pediatric Hematology/Oncology fellowship at Texas Children’s Hospital. 

    In August of 2019, Dr. Ting joined the faculty at Seattle Children’s Hospital and the University of Washington. Her clinical and research interests focus on cancer predisposition syndromes, and she established the multidisciplinary Cancer Predisposition Clinic in August of 2020. Together with other members of the Cancer and Blood Disorders Center, the goal of the Cancer Predisposition Clinic is to provide a medical home for patients with cancer predisposition syndromes and to implement cancer screening regimens for children with hereditary predisposition to cancer leading to early identification, early intervention and ultimately better outcomes.  

    Be the first to recommend Michelle Ann Ting, MD
  • Award Name Award Description Awarded By Award Date
    Family Choice Award Nomination Seattle Children's Hospital 2020
    Alex’s Lemonade Stand Foundation Travel Award Alex’s Lemonade Stand Foundation 2018
    Society for Translational Oncology Fellows’ Forum (STOFF) Rising Star in Oncology Society for Translational Oncology Fellows’ Forum (STOFF) 2018

  • Other Publications

    • Ting MA, Reuther J, Chandramohan R, Voicu H, Gandhi I, Liu M, Cortes-Santiago N, Foster JH, Hicks J, Nuchtern J, Scollon S, Plon SE, Chintagumpala M, Rainusso N, Roy A, Parsons DW
      Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
      34086347 The Journal of pathology, 2021 Sept. : 255(1)52-61
    • Ting M, Rodriguez M, Gowda ST, Anders M, Qureshi AM, Grimes A
      Cardiovascular recurrence of high-grade osteosarcoma presenting as atrial thrombosis and pulmonary embolism: A case report and review of the pediatric literature.
      31179809 Pediatric hematology and oncology, 2019 May : 36(4)244-251

    Show More Hide

Overview

Board Certification(s)

Pediatrics
Pediatric Hematology-Oncology

Medical/Professional School

University of Texas Southwestern Medical School, Dallas, TX

Residency

University of Texas Southwestern Medical Center, Dallas, TX

Fellowship

Texas Children's Hospital, Houston, TX

Clinical Interests

Solid tumors, cancer screening for children with a hereditary predisposition to cancer